1. Home
  2. GEOS vs PRQR Comparison

GEOS vs PRQR Comparison

Compare GEOS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEOS
  • PRQR
  • Stock Information
  • Founded
  • GEOS 1980
  • PRQR 2012
  • Country
  • GEOS United States
  • PRQR Netherlands
  • Employees
  • GEOS N/A
  • PRQR N/A
  • Industry
  • GEOS Industrial Machinery/Components
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEOS Industrials
  • PRQR Health Care
  • Exchange
  • GEOS Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • GEOS 249.9M
  • PRQR 224.4M
  • IPO Year
  • GEOS 1997
  • PRQR 2014
  • Fundamental
  • Price
  • GEOS $24.36
  • PRQR $2.71
  • Analyst Decision
  • GEOS
  • PRQR Strong Buy
  • Analyst Count
  • GEOS 0
  • PRQR 8
  • Target Price
  • GEOS N/A
  • PRQR $8.88
  • AVG Volume (30 Days)
  • GEOS 184.2K
  • PRQR 671.9K
  • Earning Date
  • GEOS 11-20-2025
  • PRQR 11-06-2025
  • Dividend Yield
  • GEOS N/A
  • PRQR N/A
  • EPS Growth
  • GEOS N/A
  • PRQR N/A
  • EPS
  • GEOS N/A
  • PRQR N/A
  • Revenue
  • GEOS $115,527,000.00
  • PRQR $20,129,184.00
  • Revenue This Year
  • GEOS N/A
  • PRQR N/A
  • Revenue Next Year
  • GEOS N/A
  • PRQR N/A
  • P/E Ratio
  • GEOS N/A
  • PRQR N/A
  • Revenue Growth
  • GEOS N/A
  • PRQR 8.65
  • 52 Week Low
  • GEOS $5.51
  • PRQR $1.07
  • 52 Week High
  • GEOS $24.28
  • PRQR $4.38
  • Technical
  • Relative Strength Index (RSI)
  • GEOS 61.49
  • PRQR 59.39
  • Support Level
  • GEOS $19.42
  • PRQR $2.60
  • Resistance Level
  • GEOS $24.28
  • PRQR $3.10
  • Average True Range (ATR)
  • GEOS 1.86
  • PRQR 0.24
  • MACD
  • GEOS 0.01
  • PRQR 0.05
  • Stochastic Oscillator
  • GEOS 61.70
  • PRQR 60.46

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing seismic instruments and non-seismic equipment used in the oil and gas industry. The company has three different segments: oil and gas markets, adjacent markets, and emerging markets. The oil and gas markets segment, which accounts for the majority of the company's revenue, includes traditional exploration products, wireless exploration products, and reservoir characterization products and services. The adjacent markets business is closely tied to the oil and gas markets and includes imaging products and industrial products. The company operates globally across Asia, Canada, Europe, the United States, South America, Mexico, and other regions with a majority of its revenue being generated within the United States.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: